Manufacturing channel feed – Endpoints News

The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Exclusive: Johns Hopkins professor and biotech colleagues tout new tech to test Covid-19 vaccine response

5 years ago

Thermo Fisher platform seeks to expedite donor cell cultivation for allogeneic cell therapies

5 years ago

Lonza looking to build on 'differentiated advantage' in Covid-19, CDMO marketplace in 2021

5 years ago

Flush with cash to change the generics supply chain, Civica Rx looks to break ground on first in-house manufacturing site

5 years ago

Northway Biotech sets up shop in Boston hub, looking to court more customers with biologics-focused plant

5 years ago

Lonza hits the exit on gel and liquid capsules, offloading 2 production sites to NextPharma

5 years ago

Cognate doubles manufacturing capacities in Memphis, Europe, as demand for cell and gene therapies skyrockets

5 years ago

Looking to build in red-hot viral vector space, Thermo Fisher inks $878M deal for Belgian manufacturer's 2 plants

5 years ago

Fujifilm doubles down on Boston foothold, renting some major legroom to chase cell and gene therapies

5 years ago

Acorda offloads manufacturing operations to Catalent for $70M amid latest restructuring to keep the ship afloat

5 years ago

Adaptimmune 'ready for primetime' as it prepares to launch T cell therapy for sarcoma, CEO Adrian Rawcliffe says

5 years ago

Abzena plots 6th biologics plant as demand for mammalian cell-line production continues to grow

5 years ago

Once aiming to double oncology pipeline, Servier's US branch touts rapid pace in building its foothold in the space

5 years ago

Boehringer Ingelheim permanently shelves production of clonidine, citing earlier recall and market competitors

5 years ago

After early hiccups in manufacturing, Adverum outlines plans for commercial gene therapy plant in North Carolina hub

5 years ago

Merck KGaA snaps up German CDMO in boost to mRNA portfolio — including for Covid-19

5 years ago

Moderna inks deal for overseas Covid-19 vaccine finishing work as European approval hangs in balance

5 years ago

Oncorus plots early-stage plant in Boston area as it walks I-O candidate through the clinic

5 years ago

Fast-expanding Shanghai Pharma breaks ground on $1.8B biotech park focused on next-gen R&D, antibody production

5 years ago

Amgen hands off rights to leprosy, tuberculosis med picked up as part of $13.4B Otezla deal

5 years ago

Twist Bioscience plots its 'factory of the future' in Oregon, seeks to expand synthetic DNA client base

5 years ago

Amid a busy year and new leadership, Lonza looks to build bioconjugates capacity with Swiss expansion set for 2022

5 years ago

FDA stiff arms Novartis in a surprise setback for their PCSK9 drug inclisiran

5 years ago

Taysha Gene Therapies looks to build on rapid IPO with $85M dev-manufacturing plant in North Carolina

5 years ago

First page Previous page 77 78 798081 Next page Last page